By 23andMe on Tue, 22 Jan 2019 17:03:37
23andMe received FDA clearance to report on the two most common genetic variants influencing what is called MUTYH-associated polyposis (MAP), a hereditary colorectal cancer syndrome.This new clearance is part of…
The post 23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome appeared first on 23andMe Blog.
Discover more from
Subscribe to get the latest posts sent to your email.

WOW!
LikeLiked by 1 person
I have much more information about 23&me and the FDA. All exciting.
LikeLike
Reblogged this on Survivors Blog Here.
LikeLike